Related Experiment Video
Updated: May 6, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
Lyn mitigates mouse airway remodeling by downregulating the TGF-β3 isoform in house dust mite models
Guoping Li1, John Fox, Zhigang Liu
1Department of Biochemistry and Molecular Biology, University of North Dakota, Grand Forks, ND 58203;
Abstract:
Chronic airway remodeling is a serious consequence of asthma, which is caused by complex but largely unknown mechanisms. Despite versatile functions, the role of Lyn in chronic airway remodeling remains undefined. Using Lyn(-/-) mice, we show that continual exposure (for 8 wk) of house dust mite extracts induced a severe phenotype of chronic airway remodeling, including exacerbated mucus production, collagen deposition, dysregulated cytokine secretion, and elevated inflammation. Strikingly, a significant increase in TGF-β3 rather than TGF-β1 was observed in Lyn(-/-) mouse lungs compared with lungs in wild-type mice. Furthermore, TGF-β3 neutralizing Abs not only inhibited the expression of STAT6 and Smad2/3 but also decreased phosphorylation of Smad2 and NF-κB in Lyn(-/-) mouse lungs. In addition, both recombinant and adenoviral TGF-β3 significantly promoted epithelial-to-mesenchymal transition and intensified collagen I production and MUC5AC expression. Further examination of chronic asthma patients showed that a decreased Lyn correlated with the severity of airway inflammation and mucus hypersecretion. Finally, Lyn may critically regulate airway remodeling by directly interacting with TGF-β3. Collectively, these findings revealed that Lyn regulates TGF-β3 isoform and modulates the development of airway remodeling, which may have therapeutic implications for severe chronic asthma.
Insights
The protein Lyn regulates airway remodeling in asthma by controlling TGF-β3. Loss of Lyn worsens asthma symptoms, suggesting Lyn as a therapeutic target for severe chronic asthma.
Area of Science:
- Immunology
- Cell Biology
- Pulmonology
Background:
- Chronic airway remodeling is a severe complication of asthma with poorly understood mechanisms.
- The specific role of the protein Lyn in airway remodeling is currently undefined.
Purpose of the Study:
- To investigate the role of Lyn in chronic airway remodeling.
- To explore the relationship between Lyn, TGF-β3, and asthma severity.
Main Methods:
- Utilized Lyn knockout (Lyn-/-) mice exposed to house dust mite extracts.
- Analyzed lung tissue for inflammation, mucus production, collagen deposition, and cytokine profiles.
- Investigated the effects of TGF-β3 on cellular processes and gene expression.
- Correlated Lyn levels with asthma severity in human patients.
Main Results:
- Lyn deficiency exacerbated airway remodeling, increasing mucus, collagen, inflammation, and dysregulated cytokines.
- Increased TGF-β3, but not TGF-β1, was observed in Lyn-/- mouse lungs.
- TGF-β3 inhibition reduced STAT6, Smad2/3, and NF-κB activation.
- TGF-β3 promoted epithelial-to-mesenchymal transition and MUC5AC expression.
- Reduced Lyn levels correlated with increased airway inflammation and mucus in asthma patients.
Conclusions:
- Lyn plays a critical role in regulating airway remodeling, potentially by interacting with TGF-β3.
- Targeting Lyn or TGF-β3 may offer therapeutic strategies for severe chronic asthma.
More Related Videos
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

